Anesthesiology News Buyer's Guide 2011

An

e de in om ui onl s.c G r’s ble w ye ila Ne Bu ava ogy e l Th ays sio w e al sth

is

@

e

Supplement to

2011

Buyer’s Guide Summer/Fall

3 Airway Management 7 Anesthesia Machines 10 Breathing Circuits 10 Carts 10 Infusion Systems & Pumps 10 Monitoring Systems & Devices 15 Pain Management 15 Patient Safety 15 Regional Anesthesia 17 Software & Information Systems 17 Temperature Management 18 Ultrasound

Advanced fluid therapy navigation.

The FloTrac sensor enables an individualized approach for delivering and tailoring fluid therapy for perioperative hemodynamic optimization. Used on over 775,000 patients, the FloTrac sensor is trusted by more clinicians than any other fluid management solution.

Visit Edwards.com/FloTrac to experience advanced therapy navigation.

For professional use. CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Edwards, Edwards Lifesciences, the stylized E logo, and FloTrac are trademarks of Edwards Lifesciences Corporation. © 2011 Edwards Lifesciences Corporation. All rights reserved. AR06301 edwards.com

2011

Buyer’s Guide Summer/Fall Airway Management

1

Airway Management

5

Airtraq LLC

Clarus Medical

Airtraq® Disposable Guided Video Intubation

Clarus Shikani

Address: 800 Sun Park Dr., Fenton, MO 63026 Phone: (877) 624-7929 Fax: (636) 349-3318 E-mail: info.usa@airtraq.com Web site: www.airtraq.com

Address: 1000 Boone Ave. N, Ste. 300, Minneapolis, MN 55427 Phone: (763) 525-8403 Fax: (763) 525-8656 E-mail: airway@clarus-medical.com Web site: www.clarus-medical.com/airway

Product Description: Airtraq® a disposable guided video laryngoscope for routine or challenging ET tube intubations *Sizes for Adult, Pediatric, and Infants *Optional camera and wireless monitor available *Excellent for ER, pre-hospital and med flight locations. Airtraq® ­—a simple solution for video guided intubations, where and when you need it.

Airway Management

2

Product Description: The Clarus Shikani (SOS) is a portable fiber-optic intubation scope with a malleable stylet, oxygen port and self-contained light source. The fiber optics provide clear visualization of the anatomy. The stylet is MRI safe and can be used in a variety of hospital settings. Used to place or confirm ET tubes, double‑ lumen tubes, LMAs and criqs. Airway courses and universities around the world are teaching the Shikani, while more and more hospitals are establishing it as a standard of care.

Airway Management

6

Clarus Medical

Clarus Medical

Clarus Levitan

Clarus Video System Address: 1000 Boone Ave. N, Ste. 300, Minneapolis, MN 55427 Phone: (763) 525-8403 Fax: (763) 525-8656 E-mail: airway@clarus-medical.com Web site: www.clarus-medical.com/airway

Address: 1000 Boone Ave. N, Suite 300, Minneapolis, MN 55427 Phone: (763) 525-8403 Fax: (763) 525 - 8656 E-mail: airway@clarus-medical.com Web site: www.clarus-medical.com/airway Product Description: The Clarus Video System is a malleable stylet with a digital camera. With the ET tube loaded on, navigate past the anatomy of a difficult airway and confirm placement with tracheal visualization. On-board screen and rechargeable battery make this device portable, eliminating the need for monitors, stands or towers. Additional red LED transilluminates through the skin as a lighted stylet.

Product Description: The Clarus Levitan combines the familiarity of a traditional malleable stylet with the benefits of fiberoptic visualization. The oxygen port allows for insufflation during intubation. Compatibility with GreenLine laryngoscope handles provides a backup light source if needed. The stylet is MRI safe and can be used in a variety of hospital settings. The Levitan can be used to place or confirm ET tubes, LMAs and Criqs.The Levitan is simple, portable, durable, easy to clean and affordable.

Airway Management

3

Airway Management

7

Clarus Medical

Intersurgical Inc.

Clarus Pediatric Shikani

i-gel™

Address: 1000 Boone Ave. N, Ste. 300, Minneapolis, MN 55427 Phone: (763) 525-8403 Fax: (763) 525-8656 E-mail: airway@clarus-medical.com Web site: www.clarus-medical.com/airway

Address: 417 Electronics Pkwy., Liverpool, NY 13088 Phone: (800) 828-9633 Fax: (315) 451-3696 E-mail: support@intersurgicalinc.com Web site: www.i-gel.com Product Description: The evolution continues with four new pediatric sizes. The i-gel supraglottic airway offers a quick, simple insertion with an integrated bite block, gastric channel and no cuff inflation. Secures the airway naturally, providing high seal pressures, reducing trauma and improving patient safety. Quality, innovation and choice!

Product Description: The Pediatric Shikani (SOS) is identical to the Adult Shikani, except this device is smaller and specifically designed for pediatric patients. The malleable stylet can accommodate any ET tube from size 2.5 to 5.5. Fiber-optic visualization gives you reassurance of patient safety and accurate tube placement. The stylet is MRI safe and can be used in a variety of hospital settings. With over a decade of success, the Pediatric Shikani is a trusted tool for thousands of physicians worldwide.

Airway Management

4

Airway Management

8

Clarus Medical

Karl Storz Endoscopy-America, Inc.

Clarus Pocket Scope

BONFILS Video Laryngoscope

Address: 1000 Boone Ave. N, Ste. 300, Minneapolis, MN 55427 Phone: (763) 525-8403 Fax: (763) 525-8656 E-mail: airway@clarus-medical.com Web site: www.clarus-medical.com/airway

Address: 2151 E. Grand Ave., El Segundo, CA 90245 Phone: (800) 421-0837 Fax: (800) 321-1304 E-mail: info@ksea.com Web site: www.karlstorz.com

Product Description: The Clarus Pocket Scope is a portable alternative to the traditional fiber-optic bronchoscope. This reusable fiber-optic scope is ideal for confirming the placement, position or patency of an ET tube or LMA. Instead of calling for the FOB tower, and running the risk for breakage and repair, use the pocket scope for simple confirmation. Conveniently sized, easy to clean and cost-effective, the Pocket Scope is an essential tool for the OR, MRI or ICU.

Product Description: The KARL STORZ BONFILS and BRAMBRINK optical stylets incorporate a stainless-steel shaft with a 40-degree bend designed for insertion via a retromolar approach, facilitating airway management in the most challenging situations, including C-spine, limited mouth opening and midline obstructions. Available in three sizes to accommodate neonates through obese adults.

Special Supplement I June 2011

AnesthesiologyNews.com

3

2011

Buyer’s Guide Summer/Fall Airway Management

9

Airway Management

13

Karl Storz Endoscopy-America, Inc.

LMA North America, Inc.

BRITE BLADE™ Standard Laryngoscope

LMA FASTRACH™ and FASTRACH™ SINGLE USE

Address: 2151 E. Grand Ave., El Segundo, CA 90245 Phone: (800) 421-0837 Fax: (800) 321-1304 E-mail: info@ksea.com Web site: www.karlstorz.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Product Description: The KARL STORZ Brite Blade™ Standard Laryngoscopes offer significantly improved airway visibility using patented LED illumination that provides 50,000 lux—17 times brighter than standard laryngoscopes. With its lithium-ion rechargeable battery and no bulb to change, the autoclavable Brite Blade™ Laryngoscope offers long-lasting performance and 50,000 hours of service.

Airway Management

10

Product Description: When you face a “can’t intubate/can’t ventilate” situation, you need a rescue airway you can trust.

The LMA Fastrach™ Single Use allows rapid, blind intubation without manipulating the head or neck. Simple, one-handed insertion from any position gives you immediate access to ventilate the airway while you intubate. Available in sizes 3, 4 and 5. Available in single use and reusable.

Airway Management

14

Karl Storz Endoscopy-America, Inc.

LMA North America, Inc.

C-MAC™ Video Laryngoscope

LMA Flexible™ and LMA Flexible™ Single Use

Address: 2151 E. Grand Ave., El Segundo, CA 90245 Phone: (800) 421-0837 Fax: (800) 321-1304 E-mail: info@ksea.com Web site: www.karlstorz.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Product Description: The new KARL STORZ C-MAC™ Video Laryngoscope is designed for mobile use with virtually no learning curve and provides quick and simple recording of still images and video sequences. A distally mounted CMOS chip provides at least a 60-degree field of view and an 80-degree angle of view for optimum visualization.

Product Description: When a patient is undergoing a delicate sinus, eye, ear or other ENT procedure, LMA benefits such as minimal hemodynamic response, reduced intraocular pressure, fewer drugs and smooth emergence from anesthesia are essential. That’s why the LMA Flexible™ is designed with a pliable, wire-reinforced airway tube to improve surgical access without compromising airway seal. It is available as single-use or reusable devices, in pediatric to adult sizes.

Airway Management

11

Airway Management

15

LMA North America, Inc.

LMA North America, Inc.

JED™-Jaw Elevation Device

LMA MADDY™ PEDIATRIC MUCOSAL ATOMIZATION DEVICE

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Product Description: LMA™ offers an effective airway solution for monitored anesthesia care with the JED™-Jaw Elevation Device. This new hands-free solution helps clinicians maintain an open airway during a procedure in which the patient is sedated and the airway may be compromised. The JED™ assists the provider in performing an optimal jaw thrust, eliminating the need for the clinician to manually maintain the jaw thrust during a procedure. Additionally, the JED™ may be left in place as the patient recovers following the procedure.

Product Description: Introducing the LMA MADdy™ – the ideal pediatric device to deliver topical solutions across the nasal and oropharyngeal mucous membranes.

The LMA MADdy™ delivers intranasal and intraoral medications in a fine mist which enhances absorption and improves bioavailability for fast and effective drug delivery.

Airway Management

12

Airway Management

16

LMA North America, Inc.

LMA North America, Inc.

LMA CLASSIC EXCEL™

LMA MADGIC AIRWAY™ INTUBATING AIRWAY WITH MUCOSAL ATOMIZATION AND OXYGEN DELIVERY

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com Product Description: Including all of the features of the LMA Classic™, the improved design of the LMA Classic Excel™ is reusable up to 60 times. New features help facilitate intubation in the event of an unforeseen airway complication. This new airway from LMA is a cost-effective solution for your airway needs.

4 AnesthesiologyNews.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com Product Description: Introducing the LMA MADgic ­Airway™, the most innovative choice to create a temporary airway to facilitate fiber-optic intubation. For your difficult and awake airways requiring a fiber-optic scope, the LMA MADgic Airway™ can come to the rescue combining atomized topical anesthetic and oxygen delivery in an innovative and elegantly designed fiber-optic oral airway.

Special Supplement I June 2011

2011

Buyer’s Guide Summer/Fall Airway Management

17

Airway Management

21

LMA NORTH AMERICA, INC.

LMA North America, Inc.

LMA MADGIC™ LARYNGO-TRACHEAL MUCOSAL ATOMIZATION DEVICE

the McGrath Series 5 HLDi® Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Product Description: Cross contamination between patients is a major concern for all hospitals and surgery centers, and to address this concern, Aircraft Medical has launched a new version of the valued difficult/rescue airway tool. The McGRATH® Series 5 HLDi is the only Video Laryngoscope available where the entire system can achieve high level disinfection or sterility.

Product Description: Introducing the LMA MADgic™, the most versatile choice to administer medication across the entire upper airway and beyond the vocal cords. For all of your difficult and awake intubations, bronchoscopies, transe sophageal echocardiograms and endoscopies, LMA MADgic™ will have you and your patients breathing easier with innovative features that are easy to swallow.

Airway Management

18

Airway Management

22

LMA North America, Inc.

NuMask, Inc

LMA MAD NASAL™ INTRANASAL MUCOSAL ATOMIZATION DEVICE

IntraOral Mask (IOM®) Address: 6320 Canoga Ave., Ste 1500, Woodland Hills, CA 91367 Phone: (866) NuMask1 Fax: (818) 227-5099 E-mail: customer-service@numask.com Web site: www.numask.com

Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Product Description: NuMask, Inc’s revolutionary IntraOral Mask (IOM®) utilizes the space between the gum and lips to provide leak-free mask ventilation without the challenges of body habitus, facial hair or edentulous patients. The IOM can also be used to provide preoxygenation for those with claustrophobia. Our new soft and flexible OPA provides airway support without risk for damage to teeth and oral mucosa.

With the aid of a NuMask Retention Shield, hands-free mask ventilation can be easily performed for short anesthesia cases.

Product Description: Introducing the LMA MAD Nasal™, the safe and painless way to deliver medication directly into your patient’s blood stream without an intravenous line. When IV delivery is less than ideal, LMA MAD Nasal™ can come to the rescue, delivering safe, painless and rapidly effective treatment with minimal resource utilization.

Airway Management

19

Airway Management

23

LMA North America, Inc.

Olympus America Inc.

LMA Supreme™

Olympus Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Address: 3500 Corporate Pkwy., Center Valley, PA 18034 Phone: (484) 896-5000 Fax: (484) 896-7133 E-mail: donald.reed@olympus.com Web site: www.olympusamerica.com

Product Description: The LMA Supreme™ is the first single-use LMA with a built-in drain tube. With its integrated drain tube, disposability, ease of insertion and placement verification, the LMA Supreme™ combines the best features of previous LMA masks in one device. It is simply the most advanced airway device for all of your airway needs. Supreme confidence. Supreme ease. It’s the supreme solution.

Product Description: The Olympus Airway Mobilescope, MAF-GM or MAF-TM, was designed for use anywhere, anytime—whether in the OR, ER or Educational Training Centers—it provides airway management to a wide range of hospital staff who do not have immediate access to standard video equipment. With a monitor, LED light source, battery and recording devices in a single unit, this versatile scope enables observation without peripherals or cables.

Airway Management

20

Airway Management

24

LMA North America, Inc.

Truphatek Inc.

LMA Unique™

TRUVIEW PCD—Optical Laryngoscope with video Address: 4660 La Jolla Village Dr., Ste. 900, San Diego, CA 92122 Phone: (800) 788-7999 Fax: (858) 622-4130 E-mail: custserv@lmana.com Web site: www.lmana.com

Address: 100 E. Broadway, Ashland, MO 65010 Phone: (573) 657-0907 E-mail: dwhite@truphatek.com

Product Description: For versatility, safety and proven reliability, depend on LMA Unique™—the favorite single-use airway used in millions of cases by thousands of clinicians. Made from a soft, flexible material, the LMA Unique is designed to minimize soft tissue and dental trauma, and lessen the potential for sore throat. Available in a full range of sizes from neonate to adult.

Product Description: Truview PCD optical laryngoscope with video offers maximum options for even the most challenging intubations. Optimized blade shape and angle provide superior access for restricted mouth openings and reduce trauma during intubation. Five blade sizes include three for pediatrics. Continuous oxygen flow for delayed desaturation and prevention of fogging. Can be used with any standard endoscopic camera. Modular configuration makes the PCD affordable for every hospital budget.

Special Supplement I June 2011

Fax: (573) 657-0908 Web site: www.truphatek.us

AnesthesiologyNews.com

5

2011

Buyer’s Guide Summer/Fall Airway Management

25

Airway Management

29

Verathon Medical

Vitaid Ltd.

GlideScope Cobalt AVL Video Laryngoscope

Fuji Silbroncho

Address: 20001 North Creek Pkwy., Bothell, WA 98011 Phone: (800) 331-2313 Fax: (425) 883-2896 E-mail: support@verathon.com Web site: www.glidescope.com

Address: 300 International Dr., Williamsville, NY 14221 Phone: (800) 267-9301 Fax: (800) 655-5304 E-mail: support@vitaid.com Web site: www.vitaid.com

Product Description: Optimized for OR, ED and ICU applications, the GlideScope® Cobalt AVL provides a real-time view of the airway and tube placement, enabling quick intubation. The AVL features: a digital color monitor with DVD-quality resolution and real-time recording; a reusable video baton and single-use Stat; sterile, single-use GVL® Stats available in 6 sizes for patients from preterm to morbidly obese. The NEW! GlideScope Direct intubation trainer works with AVL system to facilitate instruction of direct laryngoscopy.

Airway Management

26

Product Description: Silbroncho by Fuji Systems is a new Left and Right Double Lumen Endotracheal tube specially designed for ease of insertion. Silbroncho overcomes the problem of acutely angled left main-stem bronchi and facilitates access to ventilation of the right upper lobe as well as the middle and lower lobes without loss of effective lung separation. Made from medical grade silicone, the high volume, low pressure silicone cuffs provide extra protection from tearing while providing an excellent tracheal and bronchial seal. Specially shaped wire reinforcement of the bronchial arm allows for safe insertion and reduced incidence of kinking. Available in Right and Left sizes 33 Fr, 35 Fr, 37 Fr and 39 Fr.

Airway Management

30

Verathon Medical

Vitaid Ltd.

GlideScope Cobalt AVL Video Laryngoscope for Neonatal/Small Child Patients

Fuji TCB Univent Address: 300 International Dr., Williamsville, NY 14221 Phone: (800) 267-9301 Fax: (800) 655-5304 E-mail: support@vitaid.com Web site: www.vitaid.com

Address: 20001 North Creek Pkwy., Bothell, WA 98011 Phone: (800) 331-2313 Fax: (425) 883-2896 E-mail: support@verathon.com Web site: www.glidescope.com

Product Description: The Torque Controlled Blocker (TCB) Univent has an improved bronchial blocker for smooth intubation into the targeted bronchus. The TCB Univent’s flexible blocker shaft offers a more compliant, softer tip for smooth manipulation. Latex free, it can be directed into either left or right bronchus. Available in ID half sizes from 3.5 mm to 9.0 mm.

Product Description: Small airways are a special challenge. Designed for neonatal and small child patients, the GlideScope® Cobalt AVL 1-2 provides a consistently clear view, enabling quick intubation. The AVL features: a digital color monitor with DVD-quality resolution and realtime recording; a reusable video baton and single-use Stat; and sterile, single-use GVL® Stats available in 4 small sizes, including the NEW! 2.5 Stat.

Airway Management

27

Airway Management

31

Verathon Medical

Vitaid Ltd.

The GlideScope Video Laryngoscope

Fuji Uniblocker

Address: 20001 North Creek Pkwy., Bothell, WA 98011 Phone: (800) 331-2313 Fax: (425) 883-2896 E-mail: support@verathon.com Web site: www.glidescope.com

Address: 300 International Dr., Williamsville, NY 14221 Phone: (800) 267-9301 Fax: (800) 655-5304 E-mail: support@vitaid.com Web site: www.vitaid.com

Product Description: Reusable GlideScope® Video Laryngoscopes provide a consistently clear, real-time view of the airway and tube placement, enabling quick intubation. Four sizes let you choose the right configuration for your patients. The reusable GlideScope system features: a high-resolution camera for real-time view; an anti-fogging mechanism to resist lens contamination; and a non-glare color monitor.

Product Description: The unique Fuji Adult and Pediatric Uniblocker can be used with a standard endotracheal tube. The soft high volume low pressure silicone cuffs with gas barrier properties reduce the diffusion of gas into or out of the cuff. Uniblocker is equipped with a gas tight swivel connector with fiber-optic port and anesthesia circuit connection. The Uniblocker shaft incorporates a radiopaque metallic mesh, which gives the anesthesiologist exceptional torque control. Uniblocker available in sizes Pediatric 4.5 Fr and Adult 9 Fr.

Airway Management

28

Vitaid Ltd.

Airway Management

32

Vitaid Ltd.

Boussignac Bougie

Vygon Boussignac CPAP System

Address: 300 International Dr., Williamsville, NY 14221 Phone: (800) 267-9301 Fax: (800) 655-5304 E-mail: support@vitaid.com Web site: www.vitaid.com

Address: 300 International Dr., Williamsville, NY 14221 Phone: (800) 267-9301 Fax: (800) 655-5304 E-mail: support@vitaid.com Web site: www.vitaid.com

Product Description: The Boussignac Bougie is a conventional introducer for difficult intubation and allows for oxygenation during ET placement. The patented Boussignac Bougie reduces the risk of barotrauma with a dual lumen system for O2 delivery and a series of decompression openings allowing excess pressure to vent to atmosphere.

Available in Adult and Pediatric sizes.

Product Description: The original “Totally Open” CPAP now featuring an integral pressure relief system affording even greater patient protection from inadvertent occlusion. The new mesh head harness provides greater patient comfort. Simple to attach in the OR, no capital equipment required.

Proven effective in peer reviewed published clinical studies for the postoperative morbidly obese patient suffering dyspnea. Available in mask sizes Small, Small Adult, Medium Adult and Large Adult.

6 AnesthesiologyNews.com

Special Supplement I June 2011

2011

Buyer’s Guide Summer/Fall Anesthesia Machines

33

Anesthesia Machines

37

Anesthetic Gas Reclamation, LLC

DRÄGER

DGSS® (Dynamic Gas Scavenging System)

FABIUS GS PREMIUM

Address: 104 Woodmont Blvd., Ste. 410, Nashville, TN 37205 Phone: (615) 336-0963 Fax: (615) 463-0538 E-mail: sales@gasrecycler.com Web site: www.gasrecycler.com

Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com

Product Description: The first advance in waste anesthetic scavenging in decades, the DGSS® offers a reduction in scavenging energy and maintenance costs of up to 90%. Perfect for surgicenters but great in any location, the DGSS® is the first step to suite-wide anesthetic recycling. The DGSS® is compatible with any anesthesia machine and available now throughout the United States.

Product Description: Fabius GS Premium combines time-tested design concepts with the comfort and utility of modern digital technology. It’s an anesthesia workstation built for today and ready for the future. Export gas flows, concentrations, and waveforms to our Infinity Patient Monitoring System™ and Innovian™ Anesthesia system to enhance monitoring, charting and networking power. Its intuitive user interface, common to Dräger workstations, enables fast and precise adjustments.

Anesthesia Machines

34

anesthesia machines

38

Blue-Zone Technologies Ltd.

Dräger

Deltasorb® Canister Anesthetic Collection Service

Fabius MRI

Address: 14-84 Citation Dr., Concord, ON L4K3C1 Phone: (905) 761-1224 Fax: (905) 761-3371 E-mail: health@blue-zone.ca Web site: www.blue-zone.ca

Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com

Product Description: Deltasorb® canister provides immediate, measurable and sustainable emission reduction of waste anesthetic gas discharge. Through the use of Deltasorb® Anesthetic Collection Service, hospitals prevent the routine venting of destructive halogenated anesthetics into the environment and their neighborhoods, protect public health, reduce their carbon footprint, facilitate recycling of these valuable essential medical gases and secure savings through rebates.

Product Description: Increased diagnostic capability with state-of-the-art ventilation in the Fabius MRI anesthesia system. Specifically designed for use in magnetic environments, the Dräger Fabius MRI is certified for field strengths of up to 40 mTesla or 400 Gauss. Provides reliable ventilation with 1.5 and even 3 Tesla MRI systems. The Fabius MRI incorporates a servocontrolled piston ventilator capable of delivering higher inspiratory flows than the traditional bellows ventilator, with more accurate volume delivery.

Anesthesia Machines

35

CareFusion Pyxis Anesthesia System Address: 3750 Torrey View Ct., San Diego, CA 92130 Phone: (888) 876-4287 E-mail: contactus@carefusion.com Web site: www.carefusion.com Product Description: The Pyxis Anesthesia System helps streamline clinical workflow by providing secure, convenient access to OR medications while automatically documenting stored and dispensed drugs. It gives hospitals the accurate records they need and helps ensure anesthesia providers have the medications they need.

Anesthesia Machines

36

DRÄGER APOLLO Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com Product Description: A highly efficient anesthesia workstation, the Apollo helps manage your increasingly complex workflow. The highspeed piston ventilator works with great precision to supply a maximum peak flow far in excess of any bellows ventilator, resulting in the kind of performance previously only seen in the ICU. Its unique “Low Flow Wizard” is designed to support optimal low and minimal flow settings, which can significantly reduce the cost of inhalational anesthetic agent.

A leader in high-performance ventilation technology Special Supplement I June 2011

AnesthesiologyNews.com 7

has something new on the anesthesia horizon.

MAQUET, Inc. 45 Barbour Pond Drive Wayne, NJ 07470 www.maquetusa.com

New

Enhanced Flow Meter Visualization

It all adds up.

To a very wise investment.

60 years experience in anesthesia delivery solutions. Unparalleled performance in ventilation and vaporization. Anesthesia systems made in the U.S.A. and supported by an award winning field service team.

Consider a wise investment whose performance is based on precision, reliability and simplicity ‌ BleaseSirius.

Call (800) 522-7025 for more information. www.spacelabshealthcare.com

Connecting Innovation with Care

2011

Buyer’s Guide Summer/Fall Anesthesia Machines

39

Anesthesia Machines

43

DRÄGER

MAQUET Inc.

FABIUS TIRO

FLOW-i Anesthesia Delivery System Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com

Address: 45 Barbour Pond Dr., Wayne, NJ 07470 Phone: (888) 627-8383 Fax: (973) 709-7651 E-mail: info@maquet.com Web site: www.maquetusa.com

Product Description: Fabius Tiro combines the latest ventilation and gas-delivery technologies with an ergonomic and compact design. Adding the ability and functionality of the Dräger Infinity patient monitoring range allows you to create a workplace environment that is a good investment for the future. The open modular architecture and the software and hardware upgrade options ensure that your anesthesia workplace meets your expectations, even if you are not in the main operating room.

Product Description: Based on SERVO ventilator technology, FLOW-i is designed for the changing needs of patients and practitioners. An innovative re-breathing system replaces both the traditional bag-in-bottle and piston for quick wash-in and wash-out of anesthetic agent while providing high performance ventilation for all patient categories. Open architecture supports the patient monitor of choice.

FLOW-i is height adjustable and can be configured to satisfy a variety of workflow requirements.

Anesthesia Machines

40

Anesthesia Machines

44

DRÄGER

Mindray North America

FABIUS TIRO M

A5 Anesthesia System Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com

Address: 800 MacArthur Blvd., Mahwah, NJ 07430 Phone: (800) 288-2121 Fax: (201) 995-8612 E-mail: customerservice@mindray.com Web site: www.mindray.com

Product Description: The Fabius Tiro M was designed to provide a fullfeatured anesthesia machine in a compact, easy to assemble package for use in military medical installations in the field. The modular design allows all standard system components to be stored in a single container so that assembly and disassembly of the unit is easily accomplished.

Product Description: The A5’s advanced ventilation modes enables effective care across a wide range of patients. Its large touch-screen enables clinicians to easily select ventilation settings, so less time is spent maneuvering and more time is devoted to patient care. The A5 comes standard with VCV, PCV, PS, SIMV-VC, SIMV-PC, spirometry, warmed breathing system, central brake, mounting rails and adjustable workspace lighting. The HL7 architecture provides the industry standard interface for anesthesia information management systems.

Anesthesia Machines

41

anesthesia machines

45

GE Healthcare

Oceanic Medical

Aisys® Carestation®

Magellan Anesthesia Machine

Address: PO Box 7550, Madison, WI 53707 Phone: (800) 345-2700 Web site: www.gehealthcare.com

Address: 8005 Industrial Park Ln., Atchison, KS 66002 Phone: (913) 874-2000 E-mail: oceanicmedical@lvnworth.com Web site: www.oceanicmedical.com

Product Description: Responsive and reliable, the Aisys Care­station delivers sophisticated anesthesia therapy, advanced ventilation and dynamic patient monitoring in an innovative digital design that helps you manage routine but critical tasks efficiently. AIMS-ready design suited for EMR. Add Navigator Application Suite to analyze drug therapy to help model and predict the effect of anesthesia-related drugs.

Anesthesia Machines

42

GE Healthcare

Product Description: Oceanic manufactures a product line of FDA-cleared/CE-marked portable anesthesia delivery equipment suitable for battlefield to surgery suite and everywhere between. MRI certification available. Moderate pricing. Fully made in the USA. Specifications available at www.oceanicmedical.com.

anesthesia machines

46

Spacelabs Healthcare

Avance® Carestation®

BleaseSirius

Address: PO Box 7550, Madison, WI 53707 Phone: (800) 345-2700 Web site: www.gehealthcare.com

Address: 5150 220th Ave. SE, Issaquah, WA 98027 Phone: (425) 657-7200 Web site: www.spacelabshealthcare.com

Product Description: GE’s Avance Carestation was developed through close and continuous collaboration with clinicians. This compact, integrated Carestation combines GE’s advanced anesthesia delivery, anesthesia patient monitoring and information management in a system loaded with ergonomic enhancements. Advanced ventilation capabilities including PCV-VG, PSVPro and SIMV help address needs of the full patient range.

Product Description: From high to low acuity, simple to complex cases, pediatric to geriatric patients, we offer the choices you need in ventilation, monitoring and technique. What’s more, you can configure them to satisfy your individual practices and preferences. Spacelabs Healthcare provides comprehensive anesthesia delivery, patient monitoring, networking and interfacing solutions to meet your needs.

Special Supplement I June 2011

Fax: (425) 657-7212

AnesthesiologyNews.com

9

2011

Buyer’s Guide Summer/Fall breathing circuits

47

Monitoring Systems & Devices

51

ARC Medical, Inc.

Covidien

circuitGuard™

BIS™ Brain Monitoring Technology Address: 4296 Cowan Rd., Tucker, GA 30084 Phone: (800) 950-2720, ext. 272 Fax: (404) 373-8385 E-mail: arcinfo@arcmedical.com Web site: www.arcmedical.com

Address: 6135 Gunbarrel Ave., Boulder, CO 80301 Phone: (855) SENSING or (855) 736-7464 Web site: www.respiratorysolutions.covidien.com Product Description: The BIS™ System monitors the patient-specific effects of anesthetics and sedatives on the brain. It also provides objective insight to help you make more informed decisions about titration of sedative drugs, thereby optimizing the comfort, safety and quality of care for patients.

Product Description: Circuit protection system. Unitized construction of our filter media and housing protects circuits from contamination by patients and patients from contamination by anesthesia circuits and equipment.

Breathing Circuits

48

Monitoring Systems & Devices

52

Pall Medical

Covidien

Multiple-Patient-Use Anesthesia Circuits

INVOS™ Cerebral Somatic Oximetry System

Address: 25 Harbor Park Dr., Port Washington, NY 11050 Phone: (866) 347-3428 Fax: (734) 913-6353 E-mail: hospitalfilters@pall.com Web site: www.pall.com/reuse

Address: 6135 Gunbarrel Ave., Boulder, CO 80301 Phone: (855) SENSING or (855) 736-7464 Web site: www.respiratorysolutions.covidien.com Product Description: The INVOS™ System provides site-specific assessments on perfusion adequacy and perfusion distribution across the brain and body. Continuous monitoring of site-specific perfusion provides an early warning of developing pathology and deteriorating patient condition. The INVOS™ System provides real-time measurement and display of regional oxygen saturation (rSO2), a measure of blood oxygen saturation in the microvasculature after tissues have consumed what they need.

Product Description: Pall anesthesia circuits may be used on an unlimited number of patients within a 24-hour period, as long as each new patient receives a fresh Pall patient kit (consisting of a mask, elbow and Ultipor® 25 filter). Protect patients, staff and equipment while increasing efficiency and reducing costs and medical waste.

Carts

49

Monitoring Systems & Devices

53

Armstrong Medical Industries, Inc.

Covidien

Auto-Locking Cart with Proximity Reader

LiDCOrapid™ Advanced Hemodynamic Monitoring System

Address: 575 Knightsbridge Pkwy., Lincolnshire, IL 60069 Phone: (800) 323-4220 Fax: (847) 913-0138 E-mail: csr@armstrongmedical.com Web site: www.armstrongmedical.com

Address: 6135 Gunbarrel Ave., Boulder, CO 80301 Phone: (855) SENSING or (855) 736-7464 Web site: www.respiratorysolutions.covidien.com

Product Description: Simply wave the card in front of the reader to open. Lock the cart by pressing the lock button or set the Auto-Lock Timer for anywhere from one to 998 minutes. The Cart features lightweight aluminum construction, stabilizing frame, master code for all programming, access code for daily use, manual or automatic locking, manual key override for emergency access and “Low Battery” indicator light.

Infusion Systems & Pumps

50

Product Description: LiDCOrapid™ Advanced Hemodynamic Monitoring System provides accurate and immediate feedback on a patient’s fluid and hemodynamic status, providing a more complete view of their condition and hemodynamic response to interventions. LiDCOrapid™ offers optimized, individualized fluid management, allowing you to adjust fluid levels based on the individual needs of the patient–the right amount at the right time.

Monitoring Systems & Devices

54

Smiths Medical

Covidien

CADD®-Solis Ambulatory Infusion System, Model 2100

Nellcor™ Forehead SpO2 Sensor

Address: 1265 Grey Fox Rd., St. Paul, MN 55112 Phone: (800) 258-5361 Fax: (800) 621-2590 E-mail: info.md@smiths-medical.com Web site: www.smiths-medical.com

Address: 6135 Gunbarrel Ave., Boulder, CO 80301 Phone: (855) SENSING or (855) 736-7464 Web site: www.respiratorysolutions.covidien.com

Product Description: New patient-centered, smart and versatile infusion system to support all your pain management needs. An intuitive, task-oriented user interface promotes simplicity and patient safety. The compact, lightweight design enables patient mobility and facilitates recovery. Unique therapy-based medication safety software is designed to deploy user best-practice protocols into the pump.

Product Description: Nellcor™ Forehead SpO2 Sensors Provide: • Reliable information • Able to give readings when conventional finger sensors fail • Accurate readings • Readings are correlated with blood gas analysis and are not affected by vasoconstriction • Fast response • Can detect changes in SpO2 earlier than conventional sensors

10 AnesthesiologyNews.com

Special Supplement I June 2011

2011

Buyer’s Guide Summer/Fall Monitoring Systems & Devices

55

Monitoring Systems & Devices

59

Covidien

Edwards Lifesciences

Nellcor™ Pulse Oximetry with OxiMax™ Technology

PreSEP OXIMETRY CATHETER

Address: 6135 Gunbarrel Ave., Boulder, CO 80301 Phone: (855) SENSING or (855) 736-7464 Web site: www.respiratorysolutions.covidien.com

Address: One Edwards Way, Irvine, CA 92614 Phone: (949) 250-2500 E-mail: criticalcare@edwards.com Web site: www.edwards.com/criticalcare

Product Description: The Nellcor™ pulse oximetry platform of monitors and sensors uses cardiac-based signal processing and alarm management technologies to deliver accurate, reliable SpO2 and pulse rate readings. With the OxiMax™ pulse oximetry system, you can: • Get accurate readings, even during low perfusion.

• Improve the clinical relevance of alarms with built-in alarm management tools.

• Accurately track SpO2 in low-saturation conditions.

Monitoring Systems & Devices

56

Product Description: The PreSep oximetry catheter continuously monitors central venous oxygen saturation (ScvO2) and provides the security of an early warning by detecting critical changes in hemodynamic status earlier.

monitoring systems & devices

60

DRÄGER

Edwards Lifesciences

INFINITY® OMEGA-S SOLUTION

Swan-Ganz Catheter

Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 Fax: (215) 723-5935 E-mail: info.usa@draeger.com Web site: www.draeger.com

Address: One Edwards Way, Irvine, CA 92614 Phone: (800) 424-3278 E-mail: criticalcare@edwards.com Web site: www.edwards.com/criticalcare

Product Description: Designed for monitoring at the point of care, Infinity Omega-S features an Infinity Kappa patient monitor with a 20” wide Infinity C700 for IT workstation display. The touch screen feature allows you to quickly gain fingertip access to critical patient information.

Combined with a Dräger anesthesia workstation, Infinity Omega-S integrates live anesthesia device data with patient data management and clinical applications to support on-the-spot decision making.

Monitoring Systems & Devices

57

Product Description: Setting the gold standard in cardiac output monitoring, the advanced technology of the Swan-Ganz catheter (CCO, SvO2, RVEDV, REVEF) provides a complete picture of right heart function and insight into the balance of oxygen delivery and consumption for your most critical patients.

monitoring systems & devices

61

Edwards Lifesciences

Edwards Lifesciences

FloTrac Sensor

TruWave pressure transducer and VAMP closed blood sampling system

Address: One Edwards Way, Irvine, CA 92614 Phone: (949) 250-2500 E-mail: CriticalCare@Edwards.com Web site: www.Edwards.com/CriticalCare

Address: One Edwards Way, Irvine, CA 92614 Phone: (800) 424-3278 E-mail: criticalcare@edwards.com Web site: www.edwards.com/criticalcare

Product Description: The FloTrac sensor is the easy and reliable solution for tailored perioperative hemodynamic optimization. Less invasive, the FloTrac sensor attaches to an existing arterial catheter and automatically calculates key flow parameters such as continuous cardiac output, stroke volume, stroke volume variation and systemic vascular resistance.

monitoring systems & devices

58

Edwards Lifesciences

Product Description: Accurate and safe solutions for pressure monitoring and blood sampling, the TruWave pressure transducer and VAMP closed blood sampling system may be used independently or combined for a precise and reliable system.

Monitoring Systems & Devices

62

GE Healthcare

pediasat oximetry catheter Address: One Edwards Way, Irvine, CA 92614 Phone: (800) 595-9722 E-mail: criticalcare@edwards.com Web site: www.edwards.com/pediasat Product Description: The Edwards PediaSat oximetry catheter is the first real-time continuous oximetry (ScvO2) catheter designed for pediatrics. It can provide early indication of critical changes in a patient’s clinical condition via continuous, real-time monitoring of oxygen delivery and consumption.

Special Supplement I June 2011

CARESCAPE Monitor B650 Address: PO Box 7550, Madison, WI 53707 Phone: (800) 345-2700 Web site: www.gehealthcare.com Product Description: From the OR to the PACU, GE’s newest streamlined CARESCAPE solution can adapt to any patient need, helping to improve patient flow and deliver exceptional decision support across beds and units. Plus, the user-friendly interface and easy connectivity to hospital data takes pressure off IT staff, bringing clinical intelligence to the bedside for more informed decisions at the point of care.

AnesthesiologyNews.com

11

2011

Buyer’s Guide Summer/Fall Monitoring Systems & Devices

63

GE Healthcare

Masimo Corporation rainbow® ReSposable™ Sensor System

CARESCAPE Monitor B850 Address: PO Box 7550, Madison, WI 53707 Phone: (800) 345-2700 Web site: www.gehealthcare.com

Address: 40 Parker, Irvine, CA 92618 Phone: (800) 257-3810 Fax: (949) 297-7001 E-mail: sales@masimo.com Web site: www.masimo.com

Product Description: The product that launched GE’s new era in modular patient monitoring, CARESCAPE Monitor B850 is designed to help provide exceptional decision support for high acuity OR procedures and throughout the continuum of therapy. Advanced parameter technologies help you tailor anesthesia and detect potential problems early. The Citrix interface is designed to integrate with existing hospital networks.

Product Description: Rainbow® ReSposable Sensors offer the performance and comfort of a single-use adhesive disposable sensor with the cost-effectiveness and environmentally friendly advantages of a reusable sensor. The innovative two-piece design dramatically minimizes waste, safely reduces costs and effectively fulfills today’s “green” health care initiatives.

Monitoring Systems & Devices

64

Monitoring Systems & Devices

67

Monitoring Systems & Devices

68

Masimo Corporation

Masimo Corporation

Patient SafetyNet™ Remote Monitoring and Clinician Notification System

SEDLine® Brain Function Monitor Address: 40 Parker, Irvine, CA 92618 Phone: (800) 257-3810 E-mail: sales@masimo.com

Address: 40 Parker, Irvine, CA 92618 Phone: (800) 257-3810 Fax: (949) 297-7001 E-mail: sales@masimo.com Web site: www.masimo.com

Product Description: With demonstrated reliability under challenging clinical conditions and superior resistance to cautery, SEDLine brain function monitors feature four channels of high-quality EEG data— enabling immediate detection of asymmetrical activity and more individualized titration that helps clinicians to achieve targeted sedation and enhanced anesthetic control throughout all phases of anesthesia.

Product Description: Combining Masimo rainbow SET® Pulse CO-Oximetry and rainbow® Acoustic Monitoring with wireless clinician notifications via pager or smartphone, Patient Safety­ Net provides an unmatched level of safety for up to 80 patients on four floors—facilitating early clinical response to preempt sentinel events and avoid unnecessary ICU transfers.

Monitoring Systems & Devices

65

Monitoring Systems & Devices

69

Masimo Corporation

Mindray North America

Rad-87™ Pulse CO-Oximeter™ with Upgradeable rainbow® Technology

DPM6 Anesthesia Patient Monitor Address: 800 MacArthur Blvd., Mahwah, NJ 7430 Phone: (800) 288-2121 Fax: (201) 995-8612 E-mail: customerservice@mindray.com Web site: www.mindray.com

Address: 40 Parker, Irvine, CA 92618 Phone: (800) 257-3810 Fax: (949) 297-7001 E-mail: sales@masimo.com Web site: www.masimo.com

Product Description: DPM6™ offers 12.1-inch touch-screen capability in a scalable modular package. Targeted to the PACU, it presents a powerful combination of advanced functionality and extraordinary value. Features include ECG with arrhythmia and ST analysis, NIBP, SpO2, two standard invasive pressures, two temperatures, recorder and Oridion Microstream® or Mindray sidestream CO2 technology. The DPM6 is expandable with additional invasive pressures, CO, CCO and BIS, presented intelligently on its highresolution display.

Product Description: Featuring upgradable Masimo rainbow SET® technology and a built-in radio for wireless communication with Masimo’s Patient SafetyNet™ system, the Rad-87 Pulse CO‑Oximeter noninvasively and continuously measures: hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), acoustic respiration rate (RRa™), oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate.

Monitoring Systems & Devices

66

Masimo Corporation

Fax: (949) 297-7001 Web site: www.masimo.com

Monitoring Systems & Devices

70

Mindray North America

Radical-7™ Pulse CO-Oximeter™ Address: 40 Parker, Irvine, CA 92618 Phone: (949) 297-7000 E-mail: sales@masimo.com Web site: www.masimo.com Product Description: Radical-7 is a 3-in-1 (bedside, handheld, transport) monitor featuring Masimo rainbow SET® Pulse CO-Oximetry™—the first-and-only upgradable technology platform that continuously and noninvasively measures hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglo® ® bin (SpMet ), Pleth Variability Index (PVI ), oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate.

12 AnesthesiologyNews.com

DPM7 Anesthesia Patient Monitor Address: 800 MacArthur Blvd., Mahwah, NJ 7430 Phone: (800) 288-2121 Fax: (201) 995-8612 E-mail: customerservice@mindray.com Web site: www.mindray.com Product Description: DPM7™ offers 17-inch touch-screen capability in a modular package, targeted to the operating room. It is a powerful combination of advanced functionality and extraordinary value. Features include ECG with arrhythmia and ST analysis, NIBP, SpO2, two standard invasive pressures, two temperatures, recorder, CO2, O2, N2O and auto-ID agent gas analysis. The module rack enables up to six additional invasive pressures, CO, CCO and BIS modules. Data are presented intelligently on its high-resolution display and optional independent display.

Special Supplement I June 2011

NAROPIN® delivers a faster return of motor function than bupivacaine.1,2 A Block Well Done.

NAROPIN provides 8 to 10 hours faster return of motor function following total knee replacement than bupivacaine (P<0.05).1 To learn more about the clinical benefits of NAROPIN, visit www.naropin-us.com.

Using NAROPIN beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.

Like all amide-type local anesthetics, NAROPIN may be associated with adverse reactions.

In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.

Important Safety Information There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. NAROPIN is not approved for this use. Please see dosage and administration details in Prescribing Information at www.naropin-us.com.

Please see accompanying brief summary of Prescribing Information. www.naropin-us.com

NAROPIN is indicated for the production of regional or local anesthesia for surgery and for acute pain management.

References: 1. Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivacaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774. 2. Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth. 1994;72:164-169.

Naropin® and logo are registered trademarks of APP Pharmaceuticals, LLC. and APP ® are registered trademarks of APP Pharmaceuticals, LLC. ©2011, APP Pharmaceuticals, LLC. All Rights Reserved. 0155-NAR-05-2/11

WHY COMPROMISE?

Naropin

®

(ropivacaine HCl) Injection

BRIEF SUMMARY INDICATIONS AND USAGE Naropin is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltration. Acute Pain Management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration.

CONTRAINDICATIONS Naropin is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type.

WARNINGS In performing Naropin blocks, unintended intravenous injection is possible and may result in cardiac arrhythmia or cardiac arrest. The potential for successful resuscitation has not been studied in humans. There have been rare reports of cardiac arrest during the use of Naropin for epidural anesthesia or peripheral nerve blockade, the majority of which occurred after unintentional accidental intravascular administration in elderly patients and in patients with concomitant heart disease. In some instances, resuscitation has been difficult. Should cardiac arrest occur, prolonged resuscitative efforts may be required to improve the probability of a successful outcome. Naropin should be administered in incremental doses. It is not recommended for emergency situations, where a fast onset of surgical anesthesia is necessary. Historically, pregnant patients were reported to have a high risk for cardiac arrhythmias, cardiac/ circulatory arrest and death when 0.75% bupivacaine (another member of the amino amide class of local anesthetics) was inadvertently rapidly injected intravenously. Prior to receiving major blocks the general condition of the patient should be optimized and the patient should have an i.v. line inserted. All necessary precautions should be taken to avoid intravascular injection. Local anesthetics should only be administered by clinicians who are well versed in the diagnosis and management of dose-related toxicity and other acute emergencies that may arise from the block to be employed, and then only after ensuring the immediate (without delay) availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies (See also ADVERSE REACTIONS, PRECAUTIONS, and MANAGEMENT OF LOCAL ANESTHETIC EMERGENCIES). Delay in proper management of dose-related toxicity, underventilation from any cause, and/or altered sensitivity may lead to the development of acidosis, cardiac arrest and, possibly, death. Solutions of Naropin should not be used for the production of obstetrical paracervical block anesthesia, retrobulbar block, or spinal anesthesia (subarachnoid block) due to insufficient data to support such use. Intravenous regional anesthesia (bier block) should not be performed due to a lack of clinical experience and the risk of attaining toxic blood levels of ropivacaine. Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno-humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pain, stiffness and loss of motion can be variable, but may begin as early as the 2nd month after surgery. Currently, there is no effective treatment for chondrolysis; patients who experienced chondrolysis have required additional diagnostic and therapeutic procedures and some required arthroplasty or shoulder replacement. It is essential that aspiration for blood, or cerebrospinal fluid (where applicable), be done prior to injecting any local anesthetic, both the original dose and all subsequent doses, to avoid intravascular or subarachnoid injection. However, a negative aspiration does not ensure against an intravascular or subarachnoid injection. A well-known risk of epidural anesthesia may be an unintentional subarachnoid injection of local anesthetic. Two clinical studies have been performed to verify the safety of Naropin at a volume of 3 mL injected into the subarachnoid space since this dose represents an incremental epidural volume that could be unintentionally injected. The 15 and 22.5 mg doses injected resulted in sensory levels as high as T5 and T4, respectively. Anesthesia to pinprick started in the sacral dermatomes in 2-3 minutes, extended to the T10 level in 10-13 minutes and lasted for approximately 2 hours. The results of these two clinical studies showed that a 3 mL dose did not produce any serious adverse events when spinal anesthesia blockade was achieved. Naropin should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive. Patients treated with class III antiarrhythmic drugs (e.g., amiodarone) should be under close surveillance and ECG monitoring considered, since cardiac effects may be additive.

PRECAUTIONS: General: The safe and effective use of local anesthetics depends on proper dosage, correct technique, adequate precautions and readiness for emergencies. Resuscitative equipment, oxygen and other resuscitative drugs should be available for immediate use. (See WARNINGS and ADVERSE REACTIONS.) The lowest dosage that results in effective anesthesia should be used to avoid high plasma levels and serious adverse events. Injections should be made slowly and incrementally, with frequent aspirations before and during the injection to avoid intravascular injection. When a continuous catheter technique is used, syringe aspirations should also be performed before and during each supplemental injection. During the administration of epidural anesthesia, it is recommended that a test dose of a local anesthetic with a fast onset be administered initially and that the patient be monitored for central nervous system and cardiovascular toxicity, as well as for signs of unintended intrathecal administration before proceeding. When clinical conditions permit, consideration should be given to employing local anesthetic solutions, which contain epinephrine for the test dose because circulatory changes compatible with epinephrine may also serve as a warning sign of unintended intravascular injection. An intravascular injection is still possible even if aspirations for blood are negative. Administration of higher than recommended doses of Naropin to achieve greater motor blockade or increased duration of sensory blockade may result in cardiovascular depression, particularly in the event of inadvertent intravascular injection. Tolerance to elevated blood levels varies with the physical condition of the patient. Debilitated, elderly patients and acutely ill patients should be given reduced doses commensurate with their age and physical condition. Local anesthetics should also be used with caution in patients with hypotension, hypovolemia or heart block. Careful and constant monitoring of cardiovascular and respiratory vital signs (adequacy of ventilation) and the patient’s state of consciousness should be performed after each local anesthetic injection. It should be kept in mind at such times that restlessness, anxiety, incoherent speech, light-headedness, numbness and tingling of the mouth and lips, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, depression, or drowsiness may be early warning signs of central nervous system toxicity. Because amide-type local anesthetics such as ropivacaine are metabolized by the liver, these drugs, especially repeat doses, should be used cautiously in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations. Local anesthetics should also be used with caution in patients with impaired cardiovascular function because they may be less able to compensate for functional changes associated with the prolongation of A-V conduction produced by these drugs. Many drugs used during the conduct of anesthesia are considered potential triggering agents for malignant hyperthermia (MH). Amide-type local anesthetics are not known to trigger this reaction. However, since the need for supplemental general anesthesia cannot be predicted in advance, it is suggested that a standard protocol for MH management should be available. Epidural Anesthesia: During epidural administration, Naropin should be administered in incremental doses of 3 to 5 mL with sufficient time between doses to detect toxic manifestations of unintentional intravascular or intrathecal injection. Syringe aspirations should also be performed before and during each supplemental injection in continuous (intermittent) catheter techniques. An intravascular injection is still possible even if aspirations for blood are negative. During the administration of epidural anesthesia, it is recommended that a test dose be administered initially and the effects monitored before the full dose is given. When clinical conditions permit, the test dose should contain an appropriate dose of epinephrine to serve as a warning of unintentional intravascular injection. If injected into a blood vessel, this amount of epinephrine is likely to produce a transient “epinephrine response” within 45 seconds, consisting of an increase in heart rate and systolic blood pressure, circumoral pallor, palpitations and nervousness in the unsedated patient. The sedated patient may exhibit only a pulse rate increase of 20 or more beats per minute for 15 or more seconds. Therefore, following the test dose, the heart should be continuously monitored for a heart rate increase. Patients on beta-blockers may not manifest changes in heart rate, but blood pressure monitoring can detect a rise in systolic blood pressure. A test dose of a shortacting amide anesthetic such as lidocaine is recommended to detect an unintentional intrathecal administration. This will be manifested within a few minutes by signs of spinal block (e.g., decreased sensation of the buttocks, paresis of the legs, or, in the sedated patient, absent knee jerk). An intravascular or subarachnoid injection is still possible even if results of the test dose are negative. The test dose itself may produce a systemic toxic reaction, high spinal or epinephrine-induced cardiovascular effects. Use in Brachial Plexus Block: Ropivacine plasma concentrations may approach the threshold for central nervous system toxicity after the administration of 300 mg of ropivacaine for brachial plexus block. Caution should be exercised when using the 300 mg dose. (See OVERDOSAGE.) The dose for a major nerve block must be adjusted according to the site of administration and patient status. Supraclavicular brachial plexus blocks may be associated with a higher frequency of serious adverse reactions, regardless of the local anesthetic used. Use in Peripheral Nerve Block: Major peripheral nerve blocks may result in the administration of a large volume of local anesthetic in highly vascularized areas, often close to large vessels where there is an increased risk of intravascular injection and/or rapid systemic absorption, which can lead to high plasma concentrations. Use in Head and Neck Area: Small doses of local anesthetics injected into the head and neck area may produce adverse reactions similar to systemic toxicity seen with unintentional intravascular injections of larger doses. The injection procedures require the utmost care. Confusion, convulsions, respiratory depression, and/or respiratory arrest, and cardiovascular stimulation or depression have been reported. These reactions may be due to intra-arterial injection of the local anesthetic with retrograde flow to the cerebral circulation. Patients receiving these blocks should have their circulation and respiration monitored and be constantly observed. Resuscitative equipment and personnel for treating adverse reactions should be immediately available. Dosage recommendations should not be exceeded. (See DOSAGE AND ADMINISTRATION.) Use in Ophthalmic Surgery: The use of Naropin in retrobulbar blocks for ophthalmic surgery has not been studied. Until appropriate experience is gained, the use of Naropin for such surgery is not recommended. Drug Interactions: Specific trials studying the interaction between ropivacaine and class III antiarrhythmic drugs (e.g., amiodarone) have not been performed, but caution is advised (see WARNINGS). Naropin should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive. Cytochrome P4501A2 is involved in the formation of 3-hydroxy ropivacaine, the major metabolite. In vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor. Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of Naropin, can interact with Naropin leading to increased ropivacaine plasma levels. Caution should be exercised when CYP1A2 inhibitors are coadministered. Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as theophylline and imipramine may also occur. Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of ropivacaine. Pregnancy Category B: There are no adequate or well-controlled studies in pregnant women of the effects of Naropin on the developing fetus. Naropin should only be used during pregnancy if the benefits outweigh the risk. Labor and Delivery: Local anesthetics, including ropivacaine, rapidly cross the placenta, and when used for epidural block can cause varying degrees of maternal, fetal and neonatal toxicity (see CLINICAL PHARMACOLOGY and PHARMACOKINETICS). The incidence and degree of toxicity depend upon the procedure performed, the type and amount of drug used, and the technique of drug administration. Adverse reactions in the parturient, fetus and neonate involve alterations of the central nervous system, peripheral vascular tone and cardiac function. Maternal hypotension has resulted from regional anesthesia with Naropin for obstetrical pain relief. Local anesthetics produce vasodilation by blocking sympathetic nerves. Elevating the patient’s legs and positioning her on her left side will help prevent decreases in blood pressure. The fetal heart rate also should be monitored continuously, and electronic fetal monitoring is highly advisable. Epidural anesthesia has been reported to prolong the second stage of labor by removing the patient’s reflex urge to bear down or by interfering with motor function. Spontaneous vertex delivery occurred more frequently in patients receiving Naropin than in those receiving

bupivacaine. Nursing Mothers: Some local anesthetic drugs are excreted in human milk and caution should be exercised when they are administered to a nursing woman. The excretion of ropivacaine or its metabolites in human milk has not been studied. Based on the milk/plasma concentration ratio in rats, the estimated daily dose to a pup will be about 4% of the dose given to the mother. Assuming that the milk/plasma concentration in humans is of the same order, the total Naropin dose to which the baby is exposed by breast-feeding is far lower than by exposure in utero in pregnant women at term (see Precautions).

Pediatric Use: The safety and efficacy of Naropin in pediatric patients have not been established. Geriatric Use: Of the 2,978 subjects that were administered Naropin Injection in 71 controlled and uncontrolled clinical studies, 803 patients (27%) were 65 years of age or older, which includes 127 patients (4%) 75 years of age and over. Naropin Injection was found to be safe and effective in the patients in these studies. Clinical data in one published article indicate that differences in various pharmacodynamic measures were observed with increasing age. In one study, the upper level of analgesia increased with age, the maximum decrease of mean arterial pressure (MAP) declined with age during the first hour after epidural administration, and the intensity of motor blockade increased with age. This drug and its metabolites are known to be excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Elderly patients are more likely to have decreased hepatic, renal, or cardiac function, as well as concomitant disease. Therefore, care should be taken in dose selection, starting at the low end of the dosage range, and it may be useful to monitor renal function. (See PHARMACOKINETICS, Elimination.)

ADVERSE REACTIONS Reactions to ropivacaine are characteristic of those associated with other amidetype local anesthetics. A major cause of adverse reactions to this group of drugs may be associated with excessive plasma levels, which may be due to overdosage, unintentional intravascular injection or slow metabolic degradation. The reported adverse events are derived from clinical studies conducted in the U.S. and other countries. The reference drug was usually bupivacaine. The studies used a variety of premedications, sedatives, and surgical procedures of varying length. A total of 3,988 patients have been exposed to Naropin at concentrations up to 1.0% in clinical trials. Each patient was counted once for each type of adverse event. Incidence ≥5%: For the indications of epidural administration in surgery, cesarean section, postoperative pain management, peripheral nerve block, and local infiltration, the following treatment-emergent adverse events were reported with an incidence of ≥5% in all clinical studies (N=3988): hypotension (37.0%), nausea (24.8%), vomiting (11.6%), bradycardia (9.3%), fever (9.2%), pain (8.0%), postoperative complications (7.1%), anemia (6.1%), paresthesia (5.6%), headache (5.1%), pruritus (5.1%), and back pain (5.0%). Incidence 1-5%: Urinary retention, dizziness, rigors, hypertension, tachycardia, anxiety, oliguria, hypoesthesia, chest pain, hypokalemia, dyspnea, cramps, and urinary tract infection. Incidence in Controlled Clinical Trials: The reported adverse events are derived from controlled clinical studies with Naropin (concentrations ranged from 0.125% to 1.0% for Naropin and 0.25% to 0.75% for bupivacaine) in the U.S. and other countries involving 3,094 patients. Tables 3A and 3B list adverse events (number and percentage) that occurred in at least 1% of Naropin-treated patients in these studies. The majority of patients receiving concentrations higher than 5.0 mg/mL (0.5%) were treated with Naropin.

Table 3A Adverse Events Reported in ≥1% of Adult Patients Receiving Regional or Local Anesthesia (Surgery, Labor, Cesarean Section, Post-Operative Pain Management, Peripheral Nerve Block and Local Infiltration)

Adverse Reaction Hypotension Nausea Vomiting Bradycardia Headache Paresthesia Back pain Pain Pruritus Fever Dizziness Rigors (Chills) Postoperative complications Hypoesthesia Urinary retention Progression of labor poor/failed Anxiety Breast disorder, breast-feeding Rhinitis

N 536 283 117 96 84 82 73 71 63 61 42 42 41 27 23 23 21 21 18

Naropin total N=1661

(%) (32.3) (17.0) (7.0) (5.8) (5.1) (4.9) (4.4) (4.3) (3.8) (3.7) (2.5) (2.5) (2.5) (1.6) (1.4) (1.4) (1.3) (1.3) (1.1)

N 408 207 88 73 68 57 75 71 40 37 23 24 44 24 20 22 11 12 13

Bupivacaine total N=1433

(%) (28.5) (14.4) (6.1) (5.1) (4.7) (4.0) (5.2) (5.0) (2.8) (2.6) (1.6) (1.7) (3.1) (1.7) (1.4) (1.5) (0.8) (0.8) (0.9)

Table 3B Adverse Events Reported in ≥1% of Fetuses or Neonates of Mothers Who Received Regional Anesthesia (Cesarean Section and Labor Studies)

Adverse Reaction Fetal bradycardia Neonatal jaundice Neonatal complication-NOS Apgar score low Neonatal respiratory disorder Neonatal tachypnea Neonatal fever Fetal tachycardia Fetal distress Neonatal infection Neonatal hypoglycemia

N 77 49 42 18 17 14 13 13 11 10 8

Naropin total N=1661

(%) (12.1) (7.7) (6.6) (2.8) (2.7) (2.2) (2.0) (2.0) (1.7) (1.6) (1.3)

N 68 47 38 14 18 15 14 12 10 8 16

Bupivacaine total N=1433

(%) (11.9) (8.2) (6.6) (2.4) (3.1) (2.6) (2.4) (2.1) (1.7) (1.4) (2.8)

OVERDOSAGE Acute emergencies from local anesthetics are generally related to high plasma levels encountered, or large doses administered, during therapeutic use of local anesthetics or to unintended subarachnoid or intravascular injection of local anesthetic solution. (See ADVERSE REACTIONS, WARNINGS, and PRECAUTIONS.) MANAGEMENT OF LOCAL ANESTHETIC EMERGENCIES: Therapy with Naropin should be discontinued at the first sign of toxicity. No specific information is available for the treatment of toxicity with Naropin; therefore, treatment should be symptomatic and supportive. The first consideration is prevention, best accomplished by incremental injection of Naropin, careful and constant monitoring of cardiovascular and respiratory vital signs and the patient’s state of consciousness after each local anesthetic and during continuous infusion. At the first sign of change in mental status, oxygen should be administered. The first step in the management of systemic toxic reactions, as well as underventilation or apnea due to unintentional subarachnoid injection of drug solution, consists of immediate attention to the establishment and maintenance of a patent airway and effective assisted or controlled ventilation with 100% oxygen with a delivery system capable of permitting immediate positive airway pressure by mask. Circulation should be assisted as necessary. This may prevent convulsions if they have not already occurred. If necessary, use drugs to control convulsions. Intravenous barbiturates, anticonvulsant agents, or muscle relaxants should only be administered by those familiar with their use. Immediately after the institution of these ventilatory measures, the adequacy of the circulation should be evaluated. Supportive treatment of circulatory depression may require administration of intravenous fluids, and, when appropriate, a vasopressor dictated by the clinical situation (such as ephedrine or epinephrine to enhance myocardial contractile force). Should cardiac arrest occur, prolonged resuscitative efforts may be required to improve the probability of a successful outcome. The mean dosages of ropivacaine producing seizures, after intravenous infusion in dogs, nonpregnant and pregnant sheep were 4.9, 6.1 and 5.9 mg/kg, respectively. These doses were associated with peak arterial total plasma concentrations of 11.4, 4.3 and 5.0 μg/mL, respectively. In human volunteers given intravenous Naropin, the mean (min-max) maximum tolerated total and free arterial plasma concentrations were 4.3 (3.4-5.3) and 0.6 (0.3-0.9) μg/mL respectively, at which time moderate CNS symptoms (muscle twitching) were noted. Clinical data from patients experiencing local anesthetic induced convulsions demonstrated rapid development of hypoxia, hypercarbia and acidosis within a minute of the onset of convulsions. These observations suggest that oxygen consumption and carbon dioxide production are greatly increased during local anesthetic convulsions and emphasize the importance of immediate and effective ventilation with oxygen, which may avoid cardiac arrest. If difficulty is encountered in the maintenance of a patent airway or if prolonged ventilatory support (assisted or controlled) is indicated, endotracheal intubation, employing drugs and techniques familiar to the clinician, may be indicated after initial administration of oxygen by mask. The supine position is dangerous in pregnant women at term because of aortocaval compression by the gravid uterus. Therefore, during treatment of systemic toxicity, maternal hypotension or fetal bradycardia following regional block, the parturient should be maintained in the left lateral decubitus position if possible, or manual displacement of the uterus off the great vessels should be accomplished. Resuscitation of obstetrical patients may take longer than resuscitation of nonpregnant patients and closed-chest cardiac compression may be ineffective. Rapid delivery of the fetus may improve the response to resuscitative efforts.

APP Pharmaceuticals, LLC

0155-NAR-05-2/11

Rev. 11/08

2011

Buyer’s Guide Summer/Fall Monitoring Systems & Devices

71

Patient Safety

75

ROTEM Inc.

General Anesthetic Services, Inc.

ROTEM delta Hemostasis Analyzer

Anesthetic vaporizer service

Address: 4309 Emperor Blvd., Durham, NC 27703 Phone: (919) 941-7777 E-mail: info@roteminc.com Web site: www.roteminc.com

Address: 1900 Sleepy Hollow Rd., South Park, PA 15129 Phone: (800) 717-5955/(412) 851-4390 Fax: (412) 851-4396 E-mail: lynnefisher@gas-worldwide.us Web site: www.gas-worldwide.us

Product Description: The latest in thromboelastometry, the ROTEM delta hemostasis analyzer provides fast comprehensive data on coagulation parameters and the cause of bleeding to guide therapy, cut blood product usage and yield better patient outcomes. Used at more than 1,500 sites worldwide, the system is now cleared by the FDA to provide your surgical team critical data within 5 to 10 minutes.

monitoring systems & devices

72

Product Description: General Anesthetic Services’ focus is on patient safety. Vaporizers are life-critical devices—a part of the anesthesia machine. All too often they are overlooked. An on-site efficacy test is not a vaporizer service and calibration. The vaporizer must be sent to a proper vaporizer service center for full service and calibration. G.A.S. carries the product liability for a full three years.

Regional Anesthesia

76

Havel’s Inc.®

Salter Labs Salter Style ETCO2 Divided Sampling Cannulas

New Improved 4x4 Echogenic Corner Cube Reflector Needles (CCR®)

Address: 100 W. Sycamore Rd., Arvin, CA 93203 Phone: (800) 421-0024 Fax: (800) 628-4690 E-mail: salterlabs@us.salterlabs.com Web site: www.salterlabs.com

Address: 3726 Lonsdale St., Cincinnati, OH 45227 Phone: (800) 638-4770 Fax: (800) 628-3458 E-mail: jbarrett@havels.com Web site: www.havels.com

Product Description: SalterStyle ETCO2 Divided Sampling Cannulas feature unique permanent barriers in the face piece, and dual tubing sets and ports allowing CO2 monitoring and the concurrent administration of oxygen or gaseous analgesia.

They provide waveforms equal to those obtained with intubation, and are available in a variety of sizes and fittings.

Pain Management

73

Product Description: Havel’s EchoLine™ includes the market leading EchoStim® for ultrasound guided PNBs. Corner Cube Reflectors (CCR®) near the tip create multiple angled surfaces to reflect sound back to the transducer, even at steep insertions. The CCR® are also on the EchoBlock® for PNBs using ultrasound only, and EchoBlock® MSK, for joint injections.

Regional Anesthesia

77

Havel’s Inc.®

PAJUNK Medical Systems L.P.

Echogenic Micro Laser Etched Needles (MLE™)

CHIBA SONO

Address: 3726 Lonsdale St., Cincinnati, OH 45227 Phone: (800) 638-4770 Fax: (800) 628-3458 E-mail: jbarrett@havels.com Web site: www.havels.com

Address: 6611 Bay Circle, Ste. 100, Norcross, GA 30071 Phone: (770) 493-6832 Fax: (678) 514-3388 E-mail: richard.fischer@pajunk-usa.com Web site: www.sonoplexusa.com

Product Description: Havel’s Echoline™ includes the EchoBlock® PTC30 Needles for ultrasound guided PNBs. The Micro Laser Etching (MLE™) near the tip creates multiple surfaces to reflect sound waves back to the transducer. The MLE™ is also on the EchoBlock® PTC for shoulder, hip and knee injections, as well as the new EchoTuohy™.

Product Description: PAJUNK® has developed a new generation cannula that facilitates soft tissue biopsy using its innovative quality together with the latest in ultrasound technology. The construction and build of the cannula tip are designed so that the user can focus attention on the tip of the cannula during the complete biopsy.

regional anesthesia

74

APP Pharmaceuticals, LLC.

PAJUNK Medical Systems L.P.

NAROPIN® (ropivacaine HCl) Injection Address: 1501 East Woodfield Rd., Ste. 300 East, Schaumburg, IL 60173 Phone: (888) 386-1300 Fax: (800) 743-7082 E-mail: Naropin-contact-US@apppharma.com Web sites: www.apppharma.com, www.naropin-us.com Product Description: NAROPIN is indicated for the production of regional or local anesthesia for surgery and for acute pain management. Surgical anesthesia: epidural block for surgery including cesarean delivery; major nerve block; local infiltration. Pain management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration. NAROPIN is preservative-free and is available in 2 (0.2%), 5 (0.5%), 7.5 (0.75%) and 10 mg/mL (1%) concentrations.

Special Supplement I June 2011

Regional Anesthesia

78

TAP BLOCK SONO KIT Address: 6611 Bay Circle, Ste. 100, Norcross, GA 30071 Phone: (770) 493-6832 Fax: (678) 514-3388 E-mail: richard.fischer@pajunk-usa.com Web site: www.sonoplexusa.com Product Description: PAJUNK® has developed the Sono range of cannula, designed specifically to optimize cannula tip visibility. Ultrasound-guided TAPblocks and Rectus Sheath blocks increasingly are being used for the management of postoperative pain from abdominal surgery, but cannula tip visibility always has been a problem.

AnesthesiologyNews.com

15

â&#x201E;˘

ANESTHESIA SYSTEM

M7

D I A G N O S T I C U LT R A S O U N D S Y S T E M

healthcare within reach The Mindray A5's clear, intuitive touch screen interface simplifies operation. The explicit HL7 architecture provides ready access when integrating medical data. The precise, advanced ventilator delivers the care your patient needs. The Mindray M series ultrasound imaging systems are practical and effective procedural tools for anesthesia professionals. They enable visualization of target structures before and during anesthesia procedures. The M7 is uniquely designed to be easily accessed and used in the procedural room environment. Notable attributes include compact, portable and durable design, a sealed surface for easy cleaning and infection control, exceptional image quality and simple and intuitive operation.

Mindray North America, 800 MacArthur Blvd., Mahwah, NJ 07430 1.800.288.2121 www.na.mindray.com

2011

Buyer’s Guide Summer/Fall software & Information systems

79

Temperature Management

83

Acuitec

Arizant Healthcare Inc., a 3M company

VPIMS/vigilance

3M Bair Hugger Therapy Address: PO Box 380874, Birmingham, AL 35238 Phone: (205) 266-0848 E-mail: info@acuitec.com Web site: www.acuitec.com

Address: 10393 West 70th St., Eden Prairie, MN 55344 Phone: (800) 733-7775 Fax: (800) 775-0002 Web site: www.bairhugger.com

Product Description: VPIMS is a comprehensive perioperative and AIMS solution that arms clinicians with the information they need throughout the continuum of care, providing simultaneous patient tracking and charting of procedures with patient data monitoring. Vigilance provides anesthesiologists with remote visualization and monitoring of multiple patients simultaneously with customizable intelligent alarms. iCare is a suite of iPhone and iPad apps designed specifically for the anesthesia professional and includes remote presence, case documentation, pre-op assessment, post-op evaluation, to name a few.

software & Information systems

80

Product Description: 3M™ Bair Hugger™ therapy has become the standard of excellence in forced-air warming, providing safe, effective warming to patients around the world. Bair Hugger therapy offers more blanket styles (25) than anyone in the industry and has warmed more than 135 million patients to date. As the world’s first forced-air warming system, Bair Hugger therapy continues to innovate and define patient warming through exceptional safety, quality and performance.

Temperature Management

84

Dräger

Arizant Healthcare Inc., a 3M company

Innovian Anesthesia Address: 3135 Quarry Rd., Telford, PA 18969 Phone: (800) 437-2437 E-mail: info.usa@draeger.com

3M Bair Hugger Therapy—Underbody Series Address: 10393 West 70th St., Eden Prairie, MN 55344 Phone: (800) 733-7775 Fax: (800) 775-0002 Web site: www.bairhugger.com

Fax: (215) 723-5935 Web site: www.draeger.com

Product Description: Innovian® Anesthesia is Dräger Medical’s next-generation perianesthesia information solution. Innovian has proven success in more than 130 hospitals and 3,000 users worldwide. Innovian Anesthesia is designed to optimize and address the specific challenges of the perianesthesia process, from pre-op to intra-op and post-op/recovery, while simultaneously increasing throughput, accuracy and completeness to help you sustain a distinct competitive advantage. Innovian Anesthesia provides a comprehensive overview of a patient’s medical story, enabling patient-centric care, improved staff and patient satisfaction and the ability to track, measure and manage outcomes for improved clinical and financial results.

Software & Information Systems

81

Product Description: The 3M™ Bair Hugger™ underbody series offers a forced-air warming solution for virtually any need. For routine procedures to complex surgeries, all seven models of the Bair Hugger underbody series blankets provide full, unrestricted access to the patient and can be placed on the table before the patient arrives in the OR, simplifying OR preparation. All Bair Hugger blankets are constructed of durable, soft, radiolucent latex-free materials.

GE Healthcare

Arizant Healthcare Inc., a 3M company

Centricity Perioperative

3M Bair Paws Flex Gown

Address: 540 W. Northwest Hwy., Barrington, IL 60010 Web site: www.gehealthcare.com

Address: 10393 West 70th St., Eden Prairie, MN 55344 Phone: (800) 733-7775 Fax: (800) 775-0002 Web site: www.bairpaws.com

Product Description: Centricity* Perioperative Anesthesia is a comprehensive, integrated anesthesia information management solution designed to optimize clinical and financial outcomes. With a userfriendly touch screen design, it provides clinically rich content at the point of care to enable quick decision making and documentation.

By streamlining the capture, flow, and management of patient data throughout your facility, it can help provide more predictable patient care and revenue cycle efficiencies to jump start your ROI. *Trademark of General Electric Company.

Software & Information Systems

82

Temperature Management

85

Kuo Software, LLC

Product Description: The 3M™ Bair Paws™ flex gown combines the best of both worlds: the comfort and convenience of the Bair Paws™ gown with the proven warming of 3M™ Bair Hugger™ blankets. Separate upper and lower inserts give the gown the capability to warm for almost any need, including upper, torso or lower body warming and both clinical and comfort warming.

Patients arrive in the OR ready to warm, making the Bair Paws gown a great option for achieving normothermiarelated quality measures.

86

Temperature Management Arizant Healthcare Inc., a 3M company

Cosalient® EHR

3M Ranger blood and fluid warming system Address: PO Box 257, Issaquah, WA 98075 Phone: (800) 443-1148 Fax: (425) 654-2335 E-mail: contact@cosalient.com Web site: www.cosalient.com

Address: 10393 West 70th St., Eden Prairie, MN 55344 Phone: (800) 733-7775 Fax: (800) 775-0002 Web site: www.rangerfluidwarming.com

Product Description: Easier and faster than paper, Cosalient® EHR is the electronic documentation solution that anesthesia care providers enjoy using. Built upon the uniquely flexible, expressive and intuitive Cosalient® Document Engine–Cosalient® EHR goes beyond other anesthesia EHRs in ease of use, speed and intelligibility. Now you can have a clinician driven anesthesia EHR that preserves workflow and emphasizes caregiver satisfaction when creating true anesthesia EHR records.

Cosalient® EHR makes the time critical, intra-operative EHR usage challenge feel easy.

Product Description: The 3M™ Ranger™ blood and fluid warming system uses dry heat technology featuring microprocessor-controlled conductive warming plates that maximize heat transfer. Combined with low-resistance flow path disposables ranging from pediatric to geriatric use, the Ranger system adapts to most fluid warming needs from KVO to 30,000 mL per hour. A variety of disposable sets are available, including high flow sets with auto air elimination to help prevent a never event.

Special Supplement I June 2011

AnesthesiologyNews.com

17

2011

Buyer’s Guide Summer/Fall Temperature Management

87

Ultrasound

91

Arizant Healthcare Inc., a 3M company

Esaote

3M Ranger Irrigation System

MyLab®One

Address: 10393 West 70th St., Eden Prairie, MN 55344 Phone: (800) 733-7775 Fax: (800) 775-0002 Web site: www.rangerirrigation.com

Address: 8000 Castleway Dr., Indianapolis, IN 46250 Phone: (800) 428-4374 Fax: (317) 813-6600 E-mail: inquire@esaoteusa.com Web site: www.esaoteusa.com

Product Description: The 3M™ Ranger™ irrigation fluid warming system is an intuitive, easy-to-use solution for high-volume surgical irrigation. Unlike traditional warming cabinets where active warming ends when fluid is removed, the Ranger irrigation system warms fluid as it is delivered to the patient. Ranger’s dry heat technology monitors fluid temperatures four times each second, ensuring accurate heat control.

Product Description: The MyLab®OneRA is a high-performance, tablet ultrasound system with a simple touch-screen user interface. Developed specifically for Regional Anesthesia, the MyLabOne features a unique Anesthesia Procedure report for complete documentation, excellent IQ with 2-22 MHz range of probes, user-programmable remote control functionality, needle injection support, on-board education/tutorials for nerve block and vascular access and wireless connectivity and networking.

Temperature Management

88

Ultrasound

92

Augustine Temperature Management

Mindray North America

HotDog Patient Warming

M5 Diagnostic Ultrasound System

Address: 6581 City West Pkwy., Eden Prairie, MN 55344 Phone: (952) 746-1720 Fax: (952) 465-3501 E-mail: info@hotdog-usa.com Web site: www.hotdog-usa.com

Address: 800 MacArthur Blvd., Mahwah, NJ 7430 Phone: (800) 288-2121 Fax: (201) 995-8612 E-mail: customerservice@mindray.com Web site: www.mindray.com

Product Description: HotDog® conductive fabric warming makes this amazing offer: if you switch from forced-air to HotDog and fail to achieve a reduction in joint implant infections, then we will refund your money. How? HotDog is airfree, eliminating airborne contamination of the sterile field with rising waste heat.

Contact us for details. HotDog is also easy to use, eco-green and can save 50% over forced-air.

Temperature Management

89

Product Description: M5 is a practical, portable and durable ultrasound tool for nerve block and vascular access procedures. It provides exceptional two-dimensional gray scale and brilliant color imaging.

M5’s software features are tailored specifically for the anesthesia environment. These include iScape™ software for wider field of view, iBeam™ software to increase spatial resolution and iClear™ specklereduction software. M5 ultrasound system features are designed to easily visualize the desired anatomic region with accuracy, speed and confidence.

Ultrasound

93

Futuremed America Inc.

Mindray North America

Astotherm Plus & Astoflo Plus

M7 Diagnostic Ultrasound System

Address: 15700 Devonshire St., Granada Hills, CA 91344 Phone: (818) 830-2500 Fax: (818) 891-4755 E-mail: info@futuremedamerica.com Web site: www.futuremed.com

Address: 800 MacArthur Blvd., Mahwah, NJ 7430 Phone: (800) 288-2121 Fax: (201) 995-8612 E-mail: customerservice@mindray.com Web site: www.mindray.com

Product Description: Astotherm-Plus and Astoflo-Plus are unique, environmentally friendly warmers that bring blood and IV fluids to normal temperatures with little to no disposable. Astotherm Plus uses an economical tubing extension set, and Astoflo Plus warms fluids directly within the patient’s standard tubing. The lack of disposables eliminates waste and adds up to significant savings. Both warmers are fast and easy to set up, and have intuitive keys for temperature adjustment. Multiple independent sensors and an audio-visual alarm ensure accurate temperature control and patient safety. For more information, visit www.futuremed.com or call (800) 222-6780.

Product Description: Mindray M7 Diagnostic Ultrasound System is a premium performance procedural tool for anesthesia professionals. High-speed response, simple operation, exceptional image quality, sealed surface for easy cleaning and infection control and large 15-inch display are some of the attributes of the M7. Users can select from a full range of transducers, system carts and accessories to meet their needs. Mindray North America headquarters are in New Jersey.

Ultrasound

90

BK MEDICAL Address: 8 Centennial Dr., Peabody, MA 01960 Phone: (800) 876-7226 E-mail: info@us.bkmed.com

Ultrasonix Medical Corporation Fax: (978) 326-1300 Web site: www.bkmed.com

Product Description: BK Medical is a leading provider of premium performance ultrasound for anesthesiologists. Our systems deliver excellent image quality with superb contrast resolution and penetration, up to four hours of plug-free imaging and uncompromised flexibility. For more than 30 years we’ve pioneered innovation in ultrasound and helped to deliver better care to patients worldwide.

18 AnesthesiologyNews.com

Ultrasound

94

SonixTouch Anesthesia with GPS Address: 130 - 4311 Viking Way, Richmond, BC V6V 2K9 Phone: (866) 437-9508 Fax: (604) 279-8559 E-mail: info@ultrasonix.com Web site: www.ultrasonix.com Product Description: Ultrasonix develops and manufactures diagnostic ultrasound imaging systems with customizable touch screens to simplify workflows. SonixTOUCH Anesthesia offers unique features for nerve block guidance and vascular access, including SonixGPS, a breakthrough in needle guidance that lets you plan your trajectory before inserting the needle. Visit www.ultrasonix.com/GPS for more information.

Special Supplement I June 2011

New

Improved Ultrasound Needles for Nerve Blocks & Pain Injections At the Same Low Price!

New 4x4 Corner Cube Reflector Pattern, an Innovation by Hakko Medical, Japan.

Identify Needle Tip Location Even at Steep Angles with the Hakko EchoStim Series ®

®

Exclusively from Havel’s Inc.

Beam Reflects Back to Transducer

Patent Pending

New 4x4

Invented by Hakko Medical

EchoStim EchoBlock EchoBlock MSK ®

Focus on the Tip

®

®

CCR

®

Reflectors

Call Today for Free Sample Kit jbarrett@havels.com

® ®

3726 Lonsdale Street Cincinnati, OH 45227 www.havels.com